Home » Blog » BioBlog Weekly: Big Data in Oncology Spotlight

BioBlog Weekly: Big Data in Oncology Spotlight


IP Blog | Dave Melin | December 16, 2015

data stethoscopeThis week in health care trends, our big data in oncology spotlight includes: the coming rise in the need for daily elder care, an analysis of pharmaceutical pricing trends, and a look at the growth of national health spending in 2014.

Getting Perspective on America’s Long-Term Care Financing Crisis

As Americans continue to age, the number of patients who need hands-on daily care is growing, and so is the cost. “Roughly half of all Americans who turn 65 this year will one day need a high level of help walking, eating, and even getting out of bed. In 50 years, older Americans with this level of need will rise to 16 million, up from 6 million today. The cost of providing daily assistance can be staggering.”

From the Archives: Pharmaceutical Pricing

In this in-depth piece, Health Affairs takes a dive into the history and issues behind specialty pharmaceuticals, including different types, like biologics and small molecule drugs, and why they cost so much.

National Health Spending in 2014: Faster Growth Driven by Coverage Expansion and Prescription Drug Spending

This report examines the rate of national health spending in 2014, which “increased 5.3 percent to $3.0 trillion,” mainly, according to this report, due to “major coverage expansions under the Affordable Care Act, particularly for Medicaid and private health insurance” and “the introduction of new hepatitis C drugs, [which] contributed to rapid growth in retail prescription drug expenditures.”

Dr. Robert Green Explains Challenges, Promise of Big Data in Oncology

In this short video, Dr. Robert Green of Flatiron Health discusses how big data in oncology has grown and changed over the last few years and some of the ways big data can be “incorporated into everyday cancer care.”

Healthcare Transparency in Need of Academic Vigilance

Although the FDA requires clinical trials initiated before 2007 to submit results within 12 months of the trial’s completion, a report from STAT reveals that “researchers were either late or failed to report their results 95% of the time.”

big data cancer buttonThe articles above are from our dedicated Big Data in Oncology e-magazine. You can follow us on Flipboard or Twitter, or just watch for the links to this and our other magazines in our regular weekly BioBlog emails. (Don’t get our emails yet? Subscribe here!)


Topics in this Post:



Leave a Comment

Your email address will not be published. Required fields are marked *